...
首页> 外文期刊>Pain medicine : >Associations between heat pain perception and opioid dose among patients with chronic pain undergoing opioid tapering.
【24h】

Associations between heat pain perception and opioid dose among patients with chronic pain undergoing opioid tapering.

机译:阿片类药物逐渐减量的慢性疼痛患者的热痛知觉与阿片类药物剂量之间的关联。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The purpose of this study was to investigate the associations between morphine equivalent dose and heat pain (HP) perception in patients with chronic pain undergoing opioid tapering in the context of a multidisciplinary rehabilitation program. DESIGN: Prospective design. SETTING: Multidisciplinary pain rehabilitation center. PATIENTS: The cohort included 109 patients using opioids (female 52%) who met inclusion criteria, and were consecutively admitted from March 2007 to June 2008. INTERVENTION: Three-week outpatient multidisciplinary rehabilitation program that incorporates opioid tapering. OUTCOME MEASURES: Using a standardized quantitative sensory test (QST) method of levels, standardized values of HP perception were obtained one day following program admission and following completion of the opioid taper at program dismissal. RESULTS: At admission, the mean morphine equivalent dose was 192 mg/day. Univariate linear regression analysis showed that greater baseline morphine equivalent dose was associated (P = 0.040) with lower, or more hyperalgesic, values of HP 5-0.5, which is a standardized measure of HP perception. The dose dependent association retained significance (P = 0.029) after adjusting for pain severity, pain duration and pain diagnosis. Tapering of greater morphine equivalent dosages was associated (P = 0.001) with lower values of HP 5-0.5. The association retained significance (P = 0.001) after adjusting for pain severity, pain duration, pain diagnosis, opioid withdrawal symptoms, and time between completion of the taper and performance of the dismissal QST. CONCLUSION: The use of a validated QST method of levels and standardized values of HP 5-0.5 may expand the methodological approaches available for investigating the clinical effects of opioids on HP perception.
机译:目的:本研究旨在探讨在多学科康复计划的背景下,阿片类药物逐渐减量的慢性疼痛患者中吗啡当量剂量与热痛(HP)知觉之间的关联。设计:前瞻性设计。地点:多学科疼痛康复中心。患者:该队列包括109名使用阿片类药物的患者(符合纳入标准)(女性52%),并于2007年3月至2008年6月连续入院。干预措施:采用阿片类药物逐渐治疗的三周门诊多学科康复计划。观察指标:使用标准化的水平定量感官测试(QST)方法,在程序入院后一天和程序解除后的类鸦片锥度完成后,获得HP知觉的标准化值。结果:入院时平均吗啡当量为192毫克/天。单变量线性回归分析表明,较高的吗啡当量基线剂量与较低的或较高的痛觉过敏药HP 5-0.5值相关(P = 0.040),这是对HP知觉的标准化度量。在调整疼痛严重程度,疼痛持续时间和疼痛诊断后,剂量依赖性关联保留了显着性(P = 0.029)。吗啡当量剂量的逐渐减少与HP 5-0.5的降低有关(P = 0.001)。在调整了疼痛的严重程度,疼痛的持续时间,疼痛的诊断,阿片类药物戒断症状以及完成锥度和解除QST之间的时间后,该关联保留了显着性(P = 0.001)。结论:使用经过验证的HP 5-0.5水平和标准化值的QST方法可扩展可用于研究阿片类药物对HP知觉的临床效果的方法学方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号